↓ Skip to main content

American Association for Cancer Research

Article Metrics

ARX788, a Site-specific Anti-HER2 Antibody–Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1–resistant Breast and Gastric Cancers

Overview of attention for article published in Molecular Cancer Therapeutics, July 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
4 news outlets
twitter
2 tweeters

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
36 Mendeley